KPV

research

Anti-inflammatory tripeptide derived from alpha-MSH for gut health and skin conditions

Alpha-MSH fragment (tripeptide)
Type
SC injection / Oral capsule
Route
Yes — select vendors
Available in Thailand
Limited
Clinic therapy

Availability in Thailand

KPV is available from select Thai peptide vendors in both injectable and oral capsule forms. It is a newer addition to the peptide market and not as widely stocked as established compounds like BPC-157.

Prescription: Not required from vendors.

Legal status: Not a controlled substance in Thailand. Available as a research peptide.

Where to Buy in Thailand

KPV is a newer peptide with more limited availability. Check vendor websites for current stock and pricing.

Vendors

Synergy Peptides

Bangkok

KPV available in injectable and oral forms

View vendor →

Overview

KPV is a tripeptide (just three amino acids: Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). Despite its tiny size, it retains potent anti-inflammatory properties from its parent molecule without the skin-darkening (melanogenic) effects of full alpha-MSH or Melanotan II. This makes it valuable for pure anti-inflammatory and immune-modulating applications.

In Thailand, KPV is gaining attention in the biohacking and gut health communities. It is particularly used for inflammatory bowel conditions, skin inflammation, and general immune modulation. Like BPC-157, KPV is one of the few peptides that works orally for gut-targeted applications, making it convenient for intestinal inflammation protocols.

How It Works

NF-kB pathway inhibition

KPV inhibits the NF-kB inflammatory signalling pathway — one of the master switches for inflammation in the body. By reducing NF-kB activation, KPV decreases the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) that drive chronic inflammation.

Direct anti-inflammatory action in the gut

Research in inflammatory bowel disease models showed KPV reduces intestinal inflammation and promotes mucosal healing. When taken orally, the peptide directly contacts inflamed intestinal tissue, providing localised anti-inflammatory effects similar to how BPC-157 works for gut applications.

Immune modulation without melanogenic effects

KPV retains the immune-modulating properties of alpha-MSH — dampening excessive inflammatory responses — without activating melanocortin-1 receptors for skin pigmentation. This is pure anti-inflammatory activity without tanning side effects.

Protocol Quick Reference

starting Dose
Injection: 200-500 mcg/day. Oral: 500 mcg - 1 mg/day
maintenance Dose
Injection: 500 mcg/day. Oral: 500 mcg - 1 mg twice daily
escalation
Start with lower dose for 3-5 days to assess tolerance
injection Sites
Subcutaneous — abdomen. Oral capsules for gut-targeted effects
full Titration
3-5 days at starting dose
cycle Length
4-8 weeks for active inflammation. Can be used longer term for chronic conditions under guidance
storage
Refrigerated 2-8°C after reconstitution
reconstitution
Reconstitute with bacteriostatic water for injectable form. Capsules are pre-made
timing
Oral: on an empty stomach for gut applications. Injectable: any consistent time
special Notes
KPV and BPC-157 are sometimes used together for gut health — KPV for anti-inflammatory effects and BPC-157 for tissue repair and angiogenesis. They work through complementary mechanisms. For skin conditions, injectable delivery provides systemic distribution.

Benefits & Uses

  • Potent anti-inflammatory: Inhibits NF-kB, one of the primary drivers of chronic inflammation throughout the body
  • Gut health support: Research shows benefits for inflammatory bowel conditions — effective orally for direct intestinal action
  • Skin inflammation: Studied for inflammatory skin conditions — reduces redness, swelling, and immune-driven skin reactions
  • No tanning effects: Unlike Melanotan II, KPV provides anti-inflammatory benefits without skin darkening
  • Oral option available: Works orally for gut-targeted applications — no injections needed for intestinal inflammation
  • Very small molecule: Only 3 amino acids — simple to manufacture, generally well tolerated

Side Effects

Common

  • Mild injection site reactions
  • Mild headache — rare
  • Mild fatigue during initial use

Less Common

  • Mild nausea with oral administration
  • Mild dizziness

Serious

  • Generally well-tolerated due to its very small size and endogenous origin
  • Long-term human data for supplemental KPV is limited
  • As with any immune-modulating compound, discuss with a healthcare provider if you have autoimmune conditions

Related Peptides

FAQ

How does KPV compare to BPC-157 for gut health?

They work through different mechanisms and are often used together. BPC-157 promotes tissue repair, angiogenesis, and growth factor upregulation — it heals damaged tissue. KPV inhibits the NF-kB inflammatory pathway — it reduces the inflammation causing the damage. Together they address both the cause (inflammation) and the consequence (tissue damage).

Will KPV darken my skin like Melanotan II?

No. KPV is derived from alpha-MSH but does not activate the melanocortin-1 receptor responsible for skin pigmentation. It provides pure anti-inflammatory effects without any tanning or skin colour changes.

Can I take KPV orally?

Yes — oral KPV capsules are effective for gut-targeted applications. The peptide directly contacts inflamed intestinal tissue, providing localised anti-inflammatory effects. For systemic inflammation or skin conditions, injectable delivery is preferred.

Is KPV available in Thailand?

Yes, from select peptide vendors. It is a newer compound and not as widely available as BPC-157 or common peptides. Check our vendor directory for current stock.

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Peptides should be used under the guidance of a qualified healthcare professional. Individual results vary. Always consult your doctor before starting any peptide therapy.